Recent Updates
Recently added Catalysts
A Positive Sentiment

Agilent Introduces the NovoStation Sample Preparation System for Automated Flow Cytometry Workflows

Thursday, October 1, 2026 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Agilent Technologies has launched the NovoStation Sample Preparation System, aimed at automating flow cytometry workflows. This new platform integrates with NovoCyte flow cytometers and NovoExpress software, providing a hands-free sample-to-answer process. The system is designed to reduce the time scientists spend on sample preparation, allowing for more efficient laboratory operations.

Market Sentiment Analysis

POSITIVE FACTORS

  • Launch of an innovative automated platform.
  • Simplifies flow cytometry sample preparation.
  • Integration-ready solution enhances workflow efficiency.

Full Press Release Details

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced the launch of the NovoStation Sample Preparation System, a new automated platform designed to help laboratories simplify and streamline flow cytometry sample preparation. When paired with a NovoCyte flow cytometer and NovoExpress software, NovoStation offers an integration-ready solution that enables a hands-free sample-to-answer workflow, helping scientists spend less time preparing samples and more time

Frequently Asked Questions

What is the NovoStation Sample Preparation System?

The NovoStation is an automated platform designed to simplify flow cytometry sample preparation.

How does NovoStation improve laboratory workflows?

It enables a hands-free sample-to-answer workflow, reducing preparation time for scientists.

What systems does NovoStation integrate with?

NovoStation is designed to work with NovoCyte flow cytometers and NovoExpress software.

What benefits does the NovoStation offer?

It streamlines sample preparation, allowing scientists to focus more on analysis.

ShareAdd on Google
Tags: A Agilent Technologies NovoStation flow cytometry sample preparation NovoCyte
Last updated: Oct 1, 2026

Biotech snapshot

Cash runway
$1758M liquidity · $0M/mo burn
Low dilution risk